Results 131 to 140 of about 37,598 (173)

Invasive pneumococcal disease in the population of Victoria

Medical Journal of Australia, 2000
To estimate morbidity and mortality rates for invasive Streptococcus pneumoniae (pneumococcal) disease in the non-Indigenous population of Victoria.Survey using data from a statewide voluntary laboratory surveillance scheme (1989-1998), statewide hospital discharge database (1995-1998), medical records of notified patients (1994-1995) and serotyping of
G G, Hogg, J E, Strachan, R A, Lester
openaire   +2 more sources

Invasive Pneumococcal Disease in Children in Tonga

Pediatric Infectious Disease Journal, 2017
In Tonga, pneumococcal conjugate vaccine is not a scheduled immunization. We identified all children in Tonga with invasive pneumococcal disease from 2010 to 2013. The average annual invasive pneumococcal disease incidence rate was 113/100,000 (
Flora, Lutui, Cameron C, Grant, Emma, Best, Stephen, Howie, George, Aho   +4 more
openaire   +2 more sources

Invasive pneumococcal disease in Jamaican children

Annals of Tropical Paediatrics, 2004
A 5-year retrospective review of cases of invasive pneumococcal disease admitted to the Bustamante Hospital for Children, Jamaica was conducted. A total of 111 cases were identified. The estimated incidence of invasive pneumococcal disease in Kingston and St Andrew was 21/100,000 children under the age of 10 years.
D, McGregor, M, Barton, S, Thomas, C D, Christie   +3 more
openaire   +2 more sources

Pediatric invasive pneumococcal disease in Senegal

Médecine et Maladies Infectieuses, 2015
We aimed to describe the clinical, epidemiological, and outcome characteristics of IPD case patients hospitalized at the Albert-Royer National Children's Hospital (French acronym CHNEAR) to evaluate the disease burden of IPDs in a pediatric hospital of Dakar (Senegal).All children aged 0-15 years hospitalized at the CHNEAR between January 1st, 2008 and
I D, Ba, A, Ba, P M, Faye, A, Thiongane, M, Attiyé Kane, A, Sonko, A, Diop, I, Deme Ly, F N, Diouf, O, Ndiaye, M M M, Leye, M F, Cissé, M, Ba   +12 more
openaire   +2 more sources

Treatment and prevention of invasive pneumococcal disease

Revista Clínica Española (English Edition), 2018
Invasive pneumococcal disease is a severe infection that mainly affects patients with associated comorbidity. The paediatric conjugate vaccination has resulted in a change in the adult vaccination strategy. The antibiotic resistance of pneumococcus is not currently a severe problem.
A R, Domínguez-Alegría, V, Pintado, I, Barbolla   +2 more
openaire   +2 more sources

Invasive Pneumococcal Disease in the Immunocompromised Host

Microbial Drug Resistance, 1997
ABSTRACT A normal constituent of the human upper respiratory flora, Streptococcus pneumoniae also produces respiratory tract infections that progress to invasive disease at high rates in specific risk groups.
E N, Janoff, J B, Rubins
openaire   +2 more sources

Invasive Pneumococcal disease in Singapore children

Vaccine, 2008
Our retrospective study examined community-acquired invasive pneumococcal disease (IPD) in children admitted to KK Women's and Children's Hospital, Singapore.All pneumococcal isolates from sterile sites from 1997 to 2004 were surveyed.There were 147 positive pneumococcal isolates with a mean age of 45 months. The estimated incidence of IPD was 13.6 per
Chia-Yin, Chong, Thoon, Koh-Cheng, Mok, Yee-Hui, Tee Wen-Sim, Nancy   +3 more
openaire   +2 more sources

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease

Pediatrics, 2015
OBJECTIVE: Ten-valent pneumococcal conjugate vaccine (PCV10) was earlier shown to reduce clinically suspected, non–laboratory-confirmed invasive pneumococcal disease (IPD) in a cluster-randomized trial (the Finnish Invasive Pneumococcal disease trial).
Nuorti Pekka J, Palmu Arto A., Nohynek Hanna, Rinta-Kokko Hanna, Nuorti J. Pekka, Jokinen Jukka, Toropainen Maija, Kilpi Terhi M.   +7 more
openaire   +2 more sources

Immunodeficiency and Invasive Pneumococcal Disease

2014
This chapter focuses on the rates and clinical manifestations of invasive pneumococcal disease in patients at high risk, on proposed mechanisms of impaired defense, as well as on strategies for prevention of invasive pneumococcal disease in these groups. It describes how individual host defects may each contribute independently to the increased risk of
Edward N. Janoff, Jeffrey B. Rubins
openaire   +1 more source

Invasive Pneumococcal Disease and Pneumococcal Pneumonia

Clinical Pulmonary Medicine, 2014
Javier Aspa, Olga Rajas
openaire   +1 more source